ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.16
0.45%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.443
0.89%
Bitcoin
101,536.21
-0.48%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Biomerieux (BIM) Share Price

Biomerieux

Biomerieux (BIM)

Bindi Metals Ltd
Banca Intermobiliare SpA
110.60
0.00
(0.00%)
Closed January 21 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
110.60
Bid
110.20
Ask
110.80
Volume
0.00
0.00 Day's Range 0.00
88.25 52 Week Range 112.60
Market Cap
13.045B
Previous Close
110.60
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
105,789
Shares Outstanding
117,946,146
Dividend Yield
0.77%
PE Ratio
36.48
Earnings Per Share (EPS)
3.03
Revenue
3.67B
Net Profit
357.6M

About Biomerieux

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biomerieux.com
Headquarters
Lyon, Rhone, Fra
Founded
-
Biomerieux is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker BIM. The last closing price for Biomerieux was 110.60 €. Over the last year, Biomerieux shares have traded in a share price range of 88.25 € to 112.60 €.

Biomerieux currently has 117,946,146 shares outstanding. The market capitalization of Biomerieux is 13.04 € billion. Biomerieux has a price to earnings ratio (PE ratio) of 36.48.

Ask ADVFN Intelligence (AI)

BIM Latest News

More News

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the...

April 14 2023
Business Wire

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches Aids hospitals in...

October 21 2021
Business Wire

bioMérieux : Avis de mise à disposition des documents préparatoires à l’Assemblée générale mixte du 20 mai 2021

Regulatory News: Une Assemblée générale mixte des actionnaires de bioMérieux (Paris:BIM) (la « Société ») est convoquée le 20 mai 2021, à 14 heures, au 376, Chemin de l’Orme, 69280 Marcy...

April 09 2021
Business Wire

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

Regulatory News: bioMérieux (Paris:BIM) : Code : BIM - Code ISIN : FR0013280286 Date d’arrêt des informations Nombre d’actions Nombre total de droits de vote   31/03/2021   118 361 220 Nombre...

April 07 2021
Business Wire

bioMérieux Announces the CE Marking of TB IGRA® Test on VIDAS®

Regulatory News: Today marks World Tuberculosis (TB) Day and bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and...

March 23 2021
Business Wire

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

Regulatory News: bioMérieux (Paris:BIM), acteur majeur dans le domaine du diagnostic in vitro, annonce que sa filiale spécialisée dans les tests syndromiques des maladies infectieuses, BioFire...

March 18 2021
Business Wire

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

Regulatory News: Le Document d’enregistrement universel incluant le rapport financier annuel au 31 décembre 2020 de bioMérieux (Paris:BIM) a été déposé auprès de l'Autorité des Marchés...

March 17 2021
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.912408759124109.6111.2107.6126803109.57552483DE
48.98.75122910521101.7112.6101.791417107.42251174DE
124.13.84976525822106.5112.695.9105789102.45991913DE
261819.438444924492.6112.692.696233103.48218228DE
528.48.21917808219102.2112.688.2599798100.51703174DE
1568.48.21917808219102.2112.677.4810360096.59339558DE
26023.1526.472269868587.45144.875116825102.71637457DE

BIM - Frequently Asked Questions (FAQ)

What is the current Biomerieux share price?
The current share price of Biomerieux is 110.60 €
How many Biomerieux shares are in issue?
Biomerieux has 117,946,146 shares in issue
What is the market cap of Biomerieux?
The market capitalisation of Biomerieux is EUR 13.04B
What is the 1 year trading range for Biomerieux share price?
Biomerieux has traded in the range of 88.25 € to 112.60 € during the past year
What is the PE ratio of Biomerieux?
The price to earnings ratio of Biomerieux is 36.48
What is the cash to sales ratio of Biomerieux?
The cash to sales ratio of Biomerieux is 3.55
What is the reporting currency for Biomerieux?
Biomerieux reports financial results in EUR
What is the latest annual turnover for Biomerieux?
The latest annual turnover of Biomerieux is EUR 3.67B
What is the latest annual profit for Biomerieux?
The latest annual profit of Biomerieux is EUR 357.6M
What is the registered address of Biomerieux?
The registered address for Biomerieux is CHEMIN DE L'ORME, MARCY L’ETOILE, LYON, RHONE, 69280
What is the Biomerieux website address?
The website address for Biomerieux is www.biomerieux.com
Which industry sector does Biomerieux operate in?
Biomerieux operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCAABC Arbitrage
4.84 €
(0.00%)
0
ABAb Science
1.816 €
(0.00%)
0
AALBAalberts NV
34.34 €
(0.00%)
0
AAAAlan Allman Associates
7.20 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0
ABCAABC Arbitrage
4.84 €
(0.00%)
0
ABAb Science
1.816 €
(0.00%)
0
AALBAalberts NV
34.34 €
(0.00%)
0
AAAAlan Allman Associates
7.20 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0
ABCAABC Arbitrage
4.84 €
(0.00%)
0
ABAb Science
1.816 €
(0.00%)
0
AALBAalberts NV
34.34 €
(0.00%)
0
AAAAlan Allman Associates
7.20 €
(0.00%)
0
74SW74Software SA
27.10 €
(0.00%)
0

Discussion

View Full Feed
Investor2014 Investor2014 4 minutes ago
And you are missing Steady’s point because you are preoccupied with the FDA guidance finalisation will officially vindicate the Anavex failed co-primary endpoint and make the multiplicity rule more important.

Now that the guidance will likely not be finalised as you expected does that
AVXL
BDEZ BDEZ 5 minutes ago
Kirk: I would respect someone who received a pardon and turned it down because they know they’re innocent. But Fauci, Kinzinger, Cheney, Milley and all of the J6 Committee will of course accept because either:

1) They’re guilty as sin and they know it.

OR

CaptBeer CaptBeer 8 minutes ago
Over the years I've got to be pretty good in the science of lipidology, and since March 30, 2020 in patent law, but I have to draw the line at biostatistics. I have no friggin idea what a PS is or how to score the results using this method. 

However, since much adou has been written a
AMRN
halbroke1 halbroke1 9 minutes ago
HMBL $$$ COULD BE READY TO BLOW UP THIS WEEK...TRUMP IS IN NOW !!!...
HMBL
BDEZ BDEZ 9 minutes ago
Florida becomes the 1st state to refer to it as Gulf Of America in storm warning

https://x.com/elonmusk/status/1881540504455680103
BDEZ BDEZ 10 minutes ago
Gulf of America” has a beautiful ring to it
BDEZ BDEZ 10 minutes ago
Earlier this evening, a family member who was waiting outside the prison informed me that the prison staff were “hanging up on them” when they attempted to make calls on behalf of Lucas.

https://x.com/SarahisCensored/status/1881584704765264318
BDEZ BDEZ 10 minutes ago
Earlier this evening, a family member who was waiting outside the prison informed me that the prison staff were “hanging up on them” when they attempted to make calls on behalf of Lucas.

https://x.com/SarahisCensored/status/1881584704765264318
BDEZ BDEZ 11 minutes ago
Commies still trying to hold J6 hostages....
BDEZ BDEZ 13 minutes ago
CBS hosts complaining that they see too many whites at the inauguration

https://x.com/EndWokeness/status/1881446569037455870
BDEZ BDEZ 13 minutes ago
CBS hosts complaining that they see too many whites at the inauguration

https://x.com/EndWokeness/status/1881446569037455870
BDEZ BDEZ 14 minutes ago
And i think Rhoads as well...also great news
BDEZ BDEZ 15 minutes ago
Tarrio will or was released...good news.
BDEZ BDEZ 15 minutes ago
Ok they are not releasing many prisoners...
Investor2014 Investor2014 16 minutes ago
You are thinking something else and missing the point.
AVXL
Steady_T Steady_T 16 minutes ago
Give it a rest freeloader. Pony up a few bucks and all that goes away.
BDEZ BDEZ 18 minutes ago
Trump just fired Milley from the National Infrastructure Advisory Council
ron_66271 ron_66271 20 minutes ago
“Perpetual, non-accumulative" Preferred Shares.

Perpetual, non-accumulative preferred shares made three payments each year. Two interest payments and one Performance payment.

The CT’s function the same as Perpetual, non-accumulative" Preferred Shares.

T
JPM
Genz2 Genz2 24 minutes ago
https://www.hindustantimes.com/world-news/us-news/netizens-on-barron-trumps-classy-gesture-to-joe-biden-kamala-harris-this-kid-will-be-101737427789349-amp.html

That’s nice to see along with a great inauguration!!
RichieBoy RichieBoy 26 minutes ago
Don't dismiss Acquisition #2 That should evolve to the point of an outstanding MOU, LOI whatever all going smoothly.
AFFU
Steady_T Steady_T 26 minutes ago
That may be. We shall see. My take is that the guidance represents the FDA's thinking. That the preliminary draft was put out indicates what the FDA is thinking. Until there is something that comes out suggesting a change in that thinking, I suggest that is where the FDA is going.
It would
AVXL
Whalatane Whalatane 26 minutes ago
Hmm. theres a lot of issues with this study IMHO . We know the separation lines didn't separate for IIRC at least a year in R-IT ....but in this trial a 38% RR was achieved in 9 mths ?
I'm a fan of Laurents analysis but they used propensity scoring in this analysis . We addressed measured
AMRN
ron_66271 ron_66271 27 minutes ago
“Perpetual, non-accumulative" Preferred Shares.

Perpetual, non-accumulative preferred shares made three payments each year. Two interest payments and one Performance payment.

The same for F&F preferred of the same class.

Therefore the Perpetual, non-acc
JPM
Green Leaf Smoker Green Leaf Smoker 27 minutes ago
💩💩💩Lot of SELLERS lining (💩ing) up of MJNA @ O.OOO4 except few to no buyers at O.OOO5 of this pile of 💩
MJNA
RichieBoy RichieBoy 29 minutes ago
April 14th Holy Crud Bud I seem to recall that was the very latest they were permitted to extend the filing too. Let's hope the new CEO
(should there be one still in the dark on that one)... Will have ocassion to access the Newswire more often than our current CEO. $200 you know, that's a lot
AFFU

Your Recent History

EU
BIM
Biomerieux
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads